Among valproic acid (Depakote), vortioxetine (Trintellix), trazodone, olanzapine, and benztropine, which medication can cause hyponatremia and hypochloremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Depakote (Valproic Acid) is the Primary Culprit for Hyponatremia and Hypochloremia

Among the medications listed, Depakote (valproic acid) is most strongly associated with causing both hyponatremia and hypochloremia through SIADH (syndrome of inappropriate antidiuretic hormone secretion). Trintellix (vortioxetine) and trazodone can also cause hyponatremia as SSRIs/antidepressants, but the evidence for valproic acid is particularly compelling with documented cases of severe, life-threatening hyponatremia.

Evidence Hierarchy

Depakote (Valproic Acid) - Strongest Association

The research evidence for valproic acid causing hyponatremia is robust and alarming:

  • Case reports document serum sodium as low as 99 mEq/L with VPA overdose, one of the lowest levels ever recorded 1
  • Multiple case series show symptomatic hyponatremia and SIADH in chronic VPA users 2
  • The mechanism involves dose-dependent reduction in water excretion, confirmed through water loading tests 3
  • Vigibase analysis shows disproportionate association with hyponatremia (reporting odds ratio 1.83,95% CI 1.61-2.08) 2
  • VPA likely reduces sensitivity of hypothalamic osmoreceptors and directly affects tubular cell function 2

Clinical Pearl: Patients on chronic VPA may have baseline low sodium (one case showed 127 mEq/L baseline), making acute-on-chronic hyponatremia particularly dangerous 1.

Trintellix (Vortioxetine) - Moderate Risk

As an SSRI-class antidepressant, vortioxetine carries hyponatremia risk:

  • The FDA label explicitly warns about hyponatremia 4
  • SSRIs as a class show increased hyponatremia risk (OR 3.31,95% CI 2.41-4.56) 5
  • Risk is highest in patients ≥60 years (HR 1.29,95% CI 1.06-1.57) 6
  • The 2019 AGS Beers Criteria specifically lists tramadol (not in your list) as associated with SIADH, and notes this concern extends to antidepressants 7

Trazodone - Moderate Risk

Trazodone, classified under "other" antidepressants, shows:

  • Network meta-analysis data suggests lower risk compared to SSRIs/SNRIs 5
  • Still carries general antidepressant-class hyponatremia risk
  • Often used in combination with other medications that may compound risk

Olanzapine - Rare but Documented

While less common, olanzapine can cause hyponatremia:

  • Case reports document olanzapine-induced SIADH with severe hyponatremia and complications 8
  • Risk appears dose-dependent (case occurred after escalation from 10 to 20 mg) 8
  • Mechanism involves SIADH, similar to other psychotropics

Benztropine - No Direct Association

Benztropine (anticholinergic) is not associated with hyponatremia or hypochloremia in the provided evidence.

Monitoring Recommendations

For patients on Depakote:

  • Check baseline serum sodium before initiation
  • Monitor sodium levels at 1-2 weeks after dose changes
  • Recheck at 3 months, then every 6 months during maintenance 9
  • Consider more frequent monitoring with high doses (>2000 mg/day) 3
  • Watch for symptoms: confusion, lethargy, seizures, altered mental status

For patients on Trintellix or trazodone:

  • Baseline sodium measurement
  • Recheck within 2-4 weeks of initiation
  • Mandatory monitoring in patients ≥60 years 6
  • Consider checking at 3 months if stable

For patients on olanzapine:

  • Baseline sodium
  • Monitor if dose escalation occurs
  • Check if neurological symptoms develop

Critical Pitfalls to Avoid

  1. Don't miss acute-on-chronic hyponatremia in VPA users - baseline may already be low 1
  2. Age matters profoundly - elderly patients on SSRIs have 29% increased risk 6
  3. Polypharmacy amplifies risk - combining antidepressants with diuretics or other SIADH-inducing drugs 7
  4. Rapid correction kills - correct chronic hyponatremia slowly to avoid osmotic demyelination syndrome 10
  5. Don't ignore mild symptoms - confusion and lethargy may be the only warning before seizures 1

Hypochloremia Consideration

Hypochloremia typically accompanies hyponatremia in SIADH due to dilutional effects. Diuretics (not in your medication list) are the primary cause of isolated hypochloremia through direct chloride wasting 11, 9. Among your listed medications, valproic acid causing SIADH would produce dilutional hypochloremia alongside hyponatremia.

References

Research

Severe Hyponatremia Due to Valproic Acid Toxicity.

Journal of clinical medicine research, 2015

Research

Hyponatremia due to sodium valproate.

Annals of neurology, 1998

Research

Treatment with antidepressant drugs and hyponatremia: a network meta-analysis.

Journal of endocrinological investigation, 2025

Related Questions

What is the recommended Depakote (valproic acid) dose for a patient with hyponatraemia (serum sodium 131 mmol/L) who is currently taking valproic acid 1 g twice daily and clozapine 200 mg twice daily?
In a patient receiving clozapine 550 mg daily, valproic acid (VPA) 1000 mg, metformin 500 mg twice daily, tirzepatide, atorvastatin 20 mg, and esomeprazole 40 mg daily, could any of these medications besides clozapine cause hyponatremia?
Should hypertonic saline be given to a patient with neurological symptoms, and can valproate (valproic acid) cause hyponatremia?
Can Depakote (valproate) cause hyponatremia (low sodium levels)?
Which of the following medications—valproic acid (valproate sodium), clonazepam, zonisamide, or eslicarbazepine acetate—causes hyponatremia?
How should post‑stroke fatigue (chronic fatigue syndrome) be evaluated and managed?
When should a patient with Raynaud's phenomenon be referred to a rheumatologist?
What are the drug interactions between atomoxetine and bupropion (Wellbutrin)?
Could the temporal (temple) pain I’m experiencing be a side effect of the antibiotic I’m taking for my ear infection, in combination with an oral antihistamine and a nasal spray?
What is the appropriate meropenem dosing regimen for a patient who has developed acute respiratory distress syndrome (ARDS)?
In a nursing mother with a 7‑day history of headache and nasal congestion and new onset jaw pain, what is the appropriate evaluation plan and differential diagnosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.